Patients undergoing a long-term treatment of GnRHa (i.e., over 6 months) may have decreased muscle content, increased body fat rate, and trunk/limb fat ratio 22, suggesting that high GnRH level might be positively associated with obesity. The gene discussed is GNRH1; the disease is obesity disorder.